Company / Income Tax
West Pharmaceutical Services Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$121.6M
FY2025
5-year range
$59.0M / $122.3M
FY2021-FY2025
Trend
+13.1%
vs FY2024
Sector context
#42 of 162
Health Care
What the data says
At $122M, West Pharmaceutical Services's income tax ranks #121 of 162 in the Health Care sector. Income Tax has fluctuated over the past 10 years, ranging from $41M in FY2020 to $122M in FY2023.
Based on SEC 10-K filings.
$122M in FY2025 with a 5-year CAGR of +24.0%.
Remained stable around $122M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +18.8%
- 5-Year CAGR
- +24.0%
- 10-Year CAGR
- -
Sector benchmark
#121 of 162 in Health CareTop 74% of 162This company $121.6M Sector average $145.4M
▼
-16.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +24.0%, indicating consistent growth.
- In FY2025, income tax increased 13.1% year-over-year.
- Ranks #42 out of 162 companies in the Health Care sector.
- Peak income tax was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $121.6M | +13.1% |
| FY2024 | $107.5M | -12.1% |
| FY2023 | $122.3M | +68.7% |
| FY2022 | $72.5M | +22.9% |
| FY2021 | $59.0M | +42.5% |
| FY2020 | $41.4M | -29.8% |
| FY2019 | $59.0M | +42.5% |
| FY2018 | $41.4M | -48.8% |
| FY2017 | $80.9M | +71.4% |
| FY2016 | $47.2M | +17.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026